| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q4G8Y8 | ATP synthase subunit a; | ATPase; 6; ATP6 atp6; | NULL | 226 | human |
| D3DU39 | Chromosome 3 open reading frame 38, isoform CRA_b; | C3orf38; | XP_005264802.1; | 328 | human |
| A0A024RCM1 | MutS homolog 5 (E. coli), isoform CRA_e; | MSH5; | NULL | 834 | human |
| G5E9R0 | Actin, cytoplasmic 1; HCG15971, isoform CRA_b; | ACTB; | NULL | 125 | human |
| A0A024R5C6 | N-acetyltransferase 11, isoform CRA_a; | NAT11; | NULL | 237 | human |
| B7Z7B3 | Leucine-rich repeat-containing protein 36; cDNA FLJ55796, highly similar to Homo sapiens leucine rich repeat containing 36 (LRRC36), mRNA; | LRRC36; | NULL | 529 | human |
| A0A024QZ57 | Ceroid-lipofuscinosis, neuronal 8 (Epilepsy, progressive with mental retardation), isoform CRA_a; | CLN8; | NULL | 286 | human |
| H0UI92 | Amyloid beta (A4) protein-binding, family A, member 2 binding protein, isoform CRA_d; | APBA2BP; | NULL | 273 | human |
| D6RB80 | Dysbindin; | DTNBP1; | NULL | 46 | human |
| D6RDP0 | Protein PXYLP1; | PXYLP1; | NULL | 26 | human |
| A0A024RDF4 | Heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa), isoform CRA_e; | HNRPD; | NULL | 306 | human |
| H3BNA8 | LYR motif-containing protein 1; | LYRM1; | NULL | 33 | human |
| Q5H963 | E3 ubiquitin-protein ligase HUWE1; HECT, UBA and WWE domain containing 1; Fragment; | HUWE1; | NULL | 93 | human |
| Q7Z536 | Mucin short variant SV10; Mucin-1; | MUC1; | NULL | 149 | human |
| D3DPU0 | HCG1782708, isoform CRA_a; | NULL | NULL | 119 | human |
| D6C3F2 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| A0A024RDR6 | HCG2036544, isoform CRA_a; | NULL | NULL | 60 | human |
| Q4GI22 | Cytochrome c oxidase subunit 3; | COIII; COX3; | NULL | 261 | human |
| Q69YM1 | Putative uncharacterized protein DKFZp762C0813; Uncharacterized protein KIAA1467; Fragment; | DKFZp762C0813; KIAA1467; | NULL | 324 | human |
| D3DU83 | Ribosomal protein S2, isoform CRA_c; | RPS2; | NULL | 178 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |